SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-041091
Filing Date
2009-02-27
Accepted
2009-02-27 16:46:53
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1874587
2 CERTIFICATE OF ELIMINATION OF THE SERIES A JUNIOR PARTICIPATING PREFERRED STOCK dex34.htm EX-3.4 6827
3 FORMS OF EX-US STOCK OPTION GRANT AND RSU AGREEMENTS dex102.htm EX-10.2 44006
4 AMENDMENT AND RESTATEMENT OF THE AMGEN CHANGE OF CONTROL SEVERANCE PLAN dex1019.htm EX-10.19 30671
5 MASTER SERVICE AGREEMENT dex1071.htm EX-10.71 672954
6 INTEGRATED FACILITIES MANAGENENT SERVICES AGREEMENT dex1072.htm EX-10.72 505798
7 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 2329
8 RULE 13A-14(A) CERTIFICATIONS dex31.htm EX-31 20072
9 SECTION 1350 CERTIFICATIONS dex32.htm EX-32 9067
10 GRAPHIC g19615g15t30.jpg GRAPHIC 54766
11 GRAPHIC g19615g65t30.jpg GRAPHIC 150528
  Complete submission text file 0001193125-09-041091.txt   3450987
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 09643751
SIC: 2836 Biological Products, (No Diagnostic Substances)